Non-Alcoholic Fatty Liver Disease (NAFLD) is emerging as a significant global health concern, driven by increasing rates of obesity, diabetes and sedentary lifestyles. NAFLD includes a spectrum of ...

It encompasses a spectrum of diseases ranging from simple fatty liver to non-alcoholic steatohepatitis (NASH) and can progress to fibrosis, cirrhosis, and hepatocellular carcinoma. The global ...

A new study has revealed that About 84 per cent of the IT employees in India are suffering from Metabolic Dysfunction-Associated Fatty Liver Disease ... includes a wide spectrum of liver injury ...

Identify the warning signs of hepatitis before they become serious. From subtle fatigue to more obvious symptoms, recognizing liver inflammation early can save.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

examined the global prevalence of NAFLD and Non-Alcoholic SteatoHepatitis (NASH) in adolescents ... In the wide cardiometabolic spectrum of the disease, Polycystic ovary syndrome (PCOS) is often ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...

(NALD)(Shutterstock) According to him, NAFLD, if severe and progressing, can lead to an irreversible condition—liver cirrhosis, with non-alcoholic steatohepatitis (NASH) and liver fibrosis as ...

About 25% of NAFLD patients progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) and scarring (liver fibrosis), which can lead to cirrhosis or even ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...